GSK at Oncology Medical Congresses 2024

GSK will be at the 2024 American Society of Clinical Oncology® (ASCO®) Annual Meeting and the 2024 European Hematology Association (EHA) Hybrid Congress.

ASCO® 2024
Date: 31 May – 4 June
Location: Chicago, Illinois, US

EHA 2024
Date: 13 – 16 June
Location: Madrid, Spain

Multiple Myeloma Science Image

GSK at Oncology Medical Congresses 2024

GSK will unveil data from its oncology portfolio through 25 presentations at the 2024 American Society of Clinical Oncology® (ASCO®) Annual Meeting and 18 presentations at the European Hematology Association (EHA) 2024 Hybrid Congress. These data include compelling and highly anticipated research GSK is conducting to develop new treatment options that improve patient outcomes in complex and difficult-to-treat blood, gynaecologic and other solid tumour cancers.

This research reflects our unwavering commitment to maximising the potential of our approved and investigational therapies, alone and in combination, to improve patient lives and get ahead of disease together.

Applying precision medicine in oncology

Recent advancements in technology have allowed for the development and implementation of precision medicine practices, which can improve outcomes for those living with cancer by helping match the right patient with the right medicine at the right dose and time in their cancer journey.

Learn more from Anne-Marie Martin, GSK’s Global Head of Precision Medicine, on the research and development of precision oncology and the future of cancer treatment.

Understanding the patient experience

Patients inspire our commitment to developing new therapies for complex and difficult-to-treat cancers. Watch to learn more about their stories and unique experiences living with haematologic and gynaecologic malignancies.


Multiple Myeloma - Lou's story

Lou found comfort in connecting with the multiple myeloma community, chronicling her journey on YouTube and inspiring others.

28 March 2024

Endometrial Cancer - Andrea's story

Despite an endometrial cancer diagnosis before her wedding, Andrea has gone on to fulfil her goals and advocates for open dialogue about cancer.

31 May 2023

Ovarian cancer - Carmen's story

Carmen believes listening to one's own body plays a critical role in ensuring accurate ovarian cancer diagnosis and encourages self-advocacy.

26 May 2023

Data visualisation booth from ASCO®

We believe innovation starts when we stop to listen. We created a simple tool to include you in the conversation about how we innovate and collaborate in oncology to get ahead of disease together. Join us by meeting rooms at Booth #22023 to make your voice heard.

The content below is dynamic and will be updated with results periodically to reflect answers on-site.

  • Oncologist

  • Pharmaceuticals (R&D)

  • Pharmaceuticals (Sales)

  • Pharmaceuticals (Other)

  • Academia

  • Patient advocate

  • Focus on precision medicine and personalised treatment options

  • Advance cancer prevention and early detection

  • Foster greater access to clinical trials

  • Improve access to genetic testing and treatments

  • Harness advanced tech to improve patient experience

  • Genomics and next generation sequencing

  • Combination therapies

  • Biomarker development

  • Cell therapy advancements

  • Tumour microenvironment research

  • Transformative IO (immuno-oncology)

  • Flexible sharing and use of advanced technologies

  • Increased access to data

  • Development scalability

  • Connecting leading talent and expertise


Go behind the science

Discover how we’re uniting technology, science, and talent to get ahead of cancer.

behind the science

Advanced technology is increasing the chances of improving outcomes for cancer patients

Read the article
31 May 2024
Anaemia Blood Cells Image

behind the science

Using new science to get ahead of myelofibrosis - a rare blood cancer

Read the article
18 November 2022
T Cell And Cancer Tumour Science Image

behind the science

Biomarker testing is helping doctors identify precision treatments for patients that could dramatically improve health outcomes

Read the article
03 October 2023